Success Story
| Region/Nation | London |
|---|---|
| Sector | Manufacturing |
Vantage Power used Angel Investment to fund its technology development
Vantage Power, a battery and telemetry technology company, used Angel Investment to provide working capital while it developed its product and ran customer trials.
-
The challenge
We needed capital to fund technology development.
-
The finance
£2.3 million
-
The outcome
We secured £2.3m in funding of which the Angel Co-Fund contributed £700,000.
Vantage Power's journey to finance
- At Vantage Power we design and manufacture innovative battery packs, control systems and telemetry technologies for hybrid and electric heavy-duty vehicles. Our aim is to radically reduce harmful tailpipe emissions.
- In early 2017 we generated £2.3m in predominantly Angel Investment in 2017. Of that amount, £700,000 came via the Angel Co-Fund.
- That finance allowed us to fund technology development and provided working capital while customer trials and revenue kicked off.
- I've led the business through several rounds of funding so I was relatively confident we'd be able to secure funding.
- The process was long and it was a fairly substantial body of work, but not unreasonable given the amount of funding sought. And there was plenty of support from the Angel Co-Fund team.
Vantage Power's Top Tips
- Focus on the investors as much as how much you can raise from them.
- The benefits of having a supportive and knowledgeable investor base cannot be overstated.
- Having the emotional engagement of skilled business people can often make a substantial difference to young businesses.
The best bits about Angel Investment
- It's a long and fairly substantial body of work but not unreasonable given the amount of funding sought.
Quick links
Read a success story about Ember Transport
With support from Triodos Bank, Ember secured a £490,000 loan through the government’s Recovery Loan Scheme, which has since been relaunched as the Growth Guarantee Scheme enabled the fleet to grow to 38 vehicles, supported by Ember’s proprietary tech platform, EmberOS.
Read a success story about Ashbrook Group
Ashbrook Holdings Limited has taken a major step forward in its buy-and-build strategy with the acquisition of Webb Injection Moulders, supported by a £2m funding package structured by Arbuthnot Commercial Asset Based Lending and backed by the British Business Bank’s Growth Guarantee Scheme.
Read a success story about Magnitude Biosciences
Magnitude Biosciences, a specialist contract research organisation (CRO) in County Durham offering in vivo discovery of treatments for age-related conditions and other diseases using C. elegans, secured over £706,000 in combined funding to scale up its high-throughput screening (HTS) platform